Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-Based Instrument, the Barocycler NEP2320
WEST BRIDGEWATER, Mass., Sept. 5 -- Pressure BioSciences, Inc. (NASDAQ:PBIO) today announced that it has received approval to CE Mark the Barocycler NEP2320, a patent-pending, lightweight, compressed air driven pressure cycling technology (PCT) instrument. The Company also announced that it has been issued a CB Scheme Test Certificate and Report indicating that the Barocycler NEP2320 has been found in compliance with the IEC 61010-1 international standard applicable to safety requirements for electrical equipment for measurement, control, and laboratory use.
The NEP2320 is the second PCT-based instrument for which PBI has received CE Marking approval and CB Scheme compliance. On May 1, 2007, the Company announced approval and compliance for the Barocycler NEP3229, the current centerpiece of its PCT Sample Preparation System (PCT SPS).
Dr. Nathan P. Lawrence, Vice President of Marketing and Sales for PBI, said: "We are very pleased to have received CE Mark approval and IEC 61010-1 compliance for the Barocycler NEP2320. With approvals and compliance now in hand for both instruments of the PCT SPS, we now plan to accelerate our efforts toward reaching our goal of initiating international commercialization of the PCT Sample Preparation System in 2008. To that end, we have meetings scheduled over the next six weeks with our current distributors in France and Japan, and with potential distributors in Germany, Australia, and South Korea, all of whom have been anxiously awaiting our CE Mark and IEC 61010-1 approvals. In addition to these meetings, we also plan to immediately seek additional distributors for the PCT SPS in other countries around the world, especially in Europe and Asia."
About the Barocycler NEP2320
The NEP2320 offers a similar "look and feel" to the NEP3229, but has a system weight of approximately 75 verses 350 pounds, and processes one sample at a time, verses three for the NEP3229. Originally designed to be a demonstration unit for the larger NEP3229, the Company's market research suggested that there may be a niche in genomics and proteomics research laboratories for a Barocycler instrument with a lower sample throughput and a lower price, but with many of the technical capabilities of the higher throughput Barocycler NEP3229. Increasing European interest in PCT and the PCT SPS over the past several months has helped confirm the Company's initial market research findings.
About CE Mark and IEC 61010-1 Compliance
The CE Mark is a mandatory European marking for certain products to indicate conformity with the essential health, safety, and environmental requirements detailed in European Directives. With the approval to CE Mark its Barocycler NEP2320, Pressure BioSciences (PBI) can now market this instrument to all countries within the European Union, as well as to countries in other parts of the world that accept the CE Mark.
The CB Scheme is an international program for the exchange and acceptance of product safety test results among participating laboratories and certification organizations. The CB Scheme process offers mutual recognition of test results among participating countries, normally without the need for additional testing. The issuance of the CB Scheme Test Certificate and Report, indicating that the Barocycler NEP2320 has met the requirements of the IEC 61010-1 international standard, is another important step in PBI's efforts to commercialize and market the Barocycler NEP2320 to a number of countries worldwide, including some that do not accept the CE Mark.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions (particularly enzymes), immunodiagnostics, and protein purification.
Visit us at our website http://www.pressurebiosciences.com/
Source: Pressure BioSciences, Inc.
CONTACT: Richard T. Schumacher, President & CEO, or Edward H. Myles, Sr.
Vice President of Finance & CFO, +1-508-580-1818, both of Pressure BioSciences, Inc.
Web site: http://www.pressurebiosciences.com/
